Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma
Clinical trial NCT00086216 · COMPLETED
Trial details
- NCT number
- NCT00086216
- Sponsor
- Callisto Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.